Abstract
Background
The use of temporary prophylactic pancreatic duct (PD) stents in the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in high-risk patients has been shown to be effective in multiple trials. However, there are limited data on the clinical implications of PD stents and their impact on practice outside of the trial setting.
Methods
The utility of prophylactic pancreatic stenting was evaluated in a retrospective analysis of 1,000 consecutive ERCPs performed in a single tertiary referral pancreatobiliary center over a 24-month period, based upon a predetermined protocol to identify patients at high risk of postprocedure pancreatitis.
Results
One thousand procedures performed in 688 patients were studied. Sixty-one patients were considered for stent placement and stents were successfully placed in 58 cases. The overall rate of post-ERCP pancreatitis in our study population was 3.6%. The rate of pancreatitis in the stented patients was considered high at 22.4%, but the majority (69%) were classified as mild and there were no reported severe episodes. This compares to pancreatitis in the nonstented group, in whom the majority (73.9%) experienced either moderate or severe episodes.
Conclusion
A strategy of prophylactic PD stents in this study has eliminated severe post-ERCP pancreatitis in high-risk patients. However, the high pancreatitis rate in stented patients may represent the cost to achieve this, while stent type and size employed are likely contributing factors. To maximize the benefits of PD stenting, there is a need to identify and treat all those considered at high risk.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Singh P, Das A, Isenberg G, Wong RC, Sivak MV Jr, Agrawal D, Chak A (2004) Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 60(4):544–550
Aizawa T, Ueno N (2001) Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 54(2):209–213
Fazel A, Quadri A, Catalano MF, Meyerson SM, Geenen JE (2003) Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 57(3):291–294
Smithline A, Silverman W, Rogers D, Nisi R, Wiersema M, Jamidar P, Hawes R, Lehman G (1993) Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 39(5):652–657
Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH (1998) Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 115(6):1518–1524
Freeman ML (2007) Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 5(11):1354–1365
Williams EJ, Taylor S, Fairclough P, Hamlyn A, Logan RF, Martin D, Riley SA, Veitch P, Wilkinson M, Williamson PJ, Lombard M (2007) Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice. Gut 56(6):821–829
Fogel EL, Eversman D, Jamidar P, Sherman S, Lehman GA (2002) Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 34(4):280–285
Elmunzer BJ, Waljee AK, Elta GH, Taylor JR, Fehmi SM, Higgins PD (2008) A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 57(9):1262–1267
Freeman ML, Guda NM (2004) Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 59(7):845–864
Elta GH (2008) Temporary prophylactic pancreatic stents: which patients need them? Gastrointest Endosc 67(2):262–264
Brackbill S, Young S, Schoenfeld P, Elta G (2006) A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc 64(1):45–52
Bakman Y, Freeman ML (2009) Pancreatic stent-induced ductal injury: clinical presentation and outcomes of endoscopic therapy. Gastrointest Endosc 69(5):AB125
Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguori C, Nickl N (1991) Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37(3):383–393
Das A, Singh P, Sivak MV Jr, Chak A (2007) Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 65(7):960–968
Harewood GC, Pochron NL, Gostout CJ (2005) Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 62(3):367–370
Saad AM, Fogel EL, McHenry L, Watkins JL, Sherman S, Lazzell-Pannell L, Lehman GA (2008) Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results. Gastrointest Endosc 67(2):255–261
Rashdan A, Fogel EL, McHenry L Jr, Sherman S, Temkit M, Lehman GA (2004) Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2(4):322–329
Disclosures
Drs. P. Kennedy, E. Russo, N. Kumar, N. Powell, D. Bansi, A. Thillainayagam, P. Vlavianos, and D. Westaby have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kennedy, P.T.F., Russo, E., Kumar, N. et al. The safety and utility of prophylactic pancreatic duct stents in the prevention of post-ERCP pancreatitis: an analysis of practice in a single UK tertiary referral center. Surg Endosc 24, 1923–1928 (2010). https://doi.org/10.1007/s00464-009-0875-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-009-0875-7